Johnson & Johnson recalled all of its Tylenol products after seven people in the Chicago area died after taking Extra-Strength Tylenol capsules. The company's chair at the time, James E.

which is already causing wide debate Johnson & Johnson’s new identity is intended to reflect wider changes in the company, which now has an “exclusive focus on healthcare innovation and tackling the ...

"The company continues to believe that these claims are specious and lack scientific merit," said Erik Haas, worldwide vice president of litigation for Johnson & Johnson. But he said "resolving ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Johnson & Johnson (JNJ 0.57%) is an iconic global healthcare company. It was originally formed in 1866 when three brothers (Robert, Edward, and James Johnson) founded the company to focus on ...

Drugmaker Johnson & Johnson must pay $572m (£468m) for its part in fuelling Oklahoma's opioid addiction crisis, a judge in the US state has ruled. The company said immediately after the judgement ...

Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait. Let's delve deeper into each type of owner of Johnson & Johnson ...

Johnson & Johnson Earnings ... sales growth closer to 2% annually between 2025 and 2030. We already view the company as undervalued, and if J&J achieves its long-term guidance, there would ...

and Pharmacyclics LLC, an AbbVie company. IMBRUVICA® blocks the BTK ... key designations to nipocalimab including: At Johnson & Johnson, we believe health is everything.

"Johnson & Johnson MedTech announces partnership for soft tissue solutions" was originally created and published by Medical ...

Johnson & Johnson (NYSE:JNJ) announced that it appointed Shawn Millerick as president of Vision Care, Americas.